BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xue H, Li J, Xie H, Wang Y. Review of Drug Repositioning Approaches and Resources. Int J Biol Sci. 2018;14:1232-1244. [PMID: 30123072 DOI: 10.7150/ijbs.24612] [Cited by in Crossref: 291] [Cited by in F6Publishing: 301] [Article Influence: 72.8] [Reference Citation Analysis]
Number Citing Articles
1 Gider V, Budak C. Instruction of molecular structure similarity and scaffolds of drugs under investigation in ebola virus treatment by atom-pair and graph network: A combination of favipiravir and molnupiravir. Computational Biology and Chemistry 2022;101:107778. [DOI: 10.1016/j.compbiolchem.2022.107778] [Reference Citation Analysis]
2 Feng Z, Zhu S, Li W, Yao M, Song H, Wang R. Current approaches and strategies to identify Hedgehog signaling pathway inhibitors for cancer therapy. European Journal of Medicinal Chemistry 2022;244:114867. [DOI: 10.1016/j.ejmech.2022.114867] [Reference Citation Analysis]
3 Chen J, Chen Z, Chen R, Feng D, Li T, Han H, Bi X, Wang Z, Li K, Li Y, Li X, Wang L, Li J. HCDT: an integrated highly confident drug–target resource. Database 2022;2022. [DOI: 10.1093/database/baac101] [Reference Citation Analysis]
4 Dhanasekaran S, Selvadoss PP, Manoharan SS. Anti-Fungal Potential of Structurally Diverse FDA-Approved Therapeutics Targeting Secreted Aspartyl Proteinase (SAP) of Candida albicans: an In Silico Drug Repurposing Approach. Appl Biochem Biotechnol 2022. [DOI: 10.1007/s12010-022-04207-w] [Reference Citation Analysis]
5 Chen L, Lin D, Xu H, Li J, Lin L. WLLP: A weighted reconstruction-based linear label propagation algorithm for predicting potential therapeutic agents for COVID-19. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1040252] [Reference Citation Analysis]
6 Bhattacharjee A, Ahammad I, Chowdhury ZM, Das KC, Keya CA, Salimullah M. Proteome-Based Investigation Identified Potential Drug Repurposable Small Molecules Against Monkeypox Disease. Mol Biotechnol 2022. [DOI: 10.1007/s12033-022-00595-w] [Reference Citation Analysis]
7 Gu Y, Zheng S, Yin Q, Jiang R, Li J. REDDA: Integrating multiple biological relations to heterogeneous graph neural network for drug-disease association prediction. Computers in Biology and Medicine 2022;150:106127. [DOI: 10.1016/j.compbiomed.2022.106127] [Reference Citation Analysis]
8 Mitra D, Mitra D, Sabri Bensaad M, Sinha S, Pant K, Pant M, Priyadarshini A, Singh P, Dassamiour S, Hambaba L, Panneerselvam P, Das Mohapatra PK. Evolution of bioinformatics and its impact on modern bio-science in the twenty-first century: Special attention to pharmacology, plant science and drug discovery. Computational Toxicology 2022;24:100248. [DOI: 10.1016/j.comtox.2022.100248] [Reference Citation Analysis]
9 Kim Y, Jung Y, Park J, Kim S, Cho Y. Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning. Biomolecules 2022;12:1497. [DOI: 10.3390/biom12101497] [Reference Citation Analysis]
10 Tripathi L, Kumar P, Swain K, Pattnaik S. Drug Repurposing Based on Machine Learning. Drug Design Using Machine Learning 2022. [DOI: 10.1002/9781394167258.ch5] [Reference Citation Analysis]
11 Chugh H, Singh S. Machine Learning Applications in Rational Drug Discovery. Drug Design Using Machine Learning 2022. [DOI: 10.1002/9781394167258.ch3] [Reference Citation Analysis]
12 Ruggiero R, Balzano N, Di Napoli R, Sullo MG, Rossi F, Capuano A, Rafaniello C. Utilizing clinical pharmacology in the drug repurposing arena: a look into COVID-19. Expert Rev Clin Pharmacol 2022;:1-7. [PMID: 36196903 DOI: 10.1080/17512433.2022.2132226] [Reference Citation Analysis]
13 Barrett JS. Life Cycle Management. Fundamentals of Drug Development 2022. [DOI: 10.1002/9781119913276.ch14] [Reference Citation Analysis]
14 Sarvepalli S, Parvathaneni V, Chauhan G, Shukla SK, Gupta V. Inhaled Indomethacin-Loaded Liposomes as Potential Therapeutics against Non-Small Cell Lung Cancer (NSCLC). Pharm Res. [DOI: 10.1007/s11095-022-03392-x] [Reference Citation Analysis]
15 Zhang F, Hu W, Liu Y. GCMM: graph convolution network based on multimodal attention mechanism for drug repurposing. BMC Bioinformatics 2022;23. [DOI: 10.1186/s12859-022-04911-8] [Reference Citation Analysis]
16 Nguyen NM, Duong MTH, Bui BP, Nguyen PL, Chen X, Cho J, Ahn H. Sonidegib Suppresses Production of Inflammatory Mediators and Cell Migration in BV2 Microglial Cells and Mice Treated with Lipopolysaccharide via JNK and NF-κB Inhibition. IJMS 2022;23:10590. [DOI: 10.3390/ijms231810590] [Reference Citation Analysis]
17 Viegas C, Seck F, Fonte P. An insight on lipid nanoparticles for therapeutic proteins delivery. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103839] [Reference Citation Analysis]
18 Kuo TC, Wang PH, Wang YK, Chang CI, Chang CY, Tseng YJ. RSDB: A rare skin disease database to link drugs with potential drug targets for rare skin diseases. Sci Data 2022;9:521. [PMID: 36028515 DOI: 10.1038/s41597-022-01654-2] [Reference Citation Analysis]
19 Zhong S, Shengyu Liu, Xin Shi, Zhang X, Li K, Liu G, Li L, Tao S, Zheng B, Sheng W, Ye Z, Xing Q, Zhai Q, Ren L, Wu Y, Bao Y. Disulfiram in glioma: Literature review of drug repurposing. Front Pharmacol 2022;13:933655. [DOI: 10.3389/fphar.2022.933655] [Reference Citation Analysis]
20 Cheng X, Qu J, Song S, Bian Z. Neighborhood-based inference and restricted Boltzmann machine for microbe and drug associations prediction. PeerJ 2022;10:e13848. [DOI: 10.7717/peerj.13848] [Reference Citation Analysis]
21 Zhang L, Au-yeung C, Huang C, Yeung T, Ferri-borgogno S, Lawson BC, Kwan S, Yin Z, Wong ST, Thomas V, Lu KH, Yip K, Sham JSK, Mok SC. Ryanodine receptor 1-mediated Ca2+ signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypes. J Exp Clin Cancer Res 2022;41:242. [DOI: 10.1186/s13046-022-02419-w] [Reference Citation Analysis]
22 Siddiqui S, Deshmukh AJ, Mudaliar P, Nalawade AJ, Iyer D, Aich J. Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review. J Egypt Natl Canc Inst 2022;34. [DOI: 10.1186/s43046-022-00137-0] [Reference Citation Analysis]
23 Brasil S, Allocca M, Magrinho SCM, Santos I, Raposo M, Francisco R, Pascoal C, Martins T, Videira PA, Pereira F, Andreotti G, Jaeken J, Kantautas KA, Perlstein EO, Ferreira VDR. Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG). Int J Mol Sci 2022;23:8725. [PMID: 35955863 DOI: 10.3390/ijms23158725] [Reference Citation Analysis]
24 Paruchuri S, Yetukuri K, Nadendla R. Repurposing Molnupiravir as a new opportunity to treat COVID-19. Journal of Generic Medicines 2022. [DOI: 10.1177/17411343221115819] [Reference Citation Analysis]
25 Kumbhar P, Kole K, Khadake V, Marale P, Manjappa A, Nadaf S, Jadhav R, Patil A, Singh SK, Dua K, Jha NK, Disouza J, Patravale V. Nanoparticulate drugs and vaccines: Breakthroughs and bottlenecks of repurposing in breast cancer. J Control Release 2022;349:812-30. [PMID: 35914614 DOI: 10.1016/j.jconrel.2022.07.039] [Reference Citation Analysis]
26 Niranjan V, Setlur AS, Karunakaran C, Uttarkar A, Kumar KM, Skariyachan S. Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2. Struct Chem. [DOI: 10.1007/s11224-022-02020-z] [Reference Citation Analysis]
27 Xavier MR, Freitas TS, Pereira RLS, Marinho EM, Bandeira PN, de Sousa AP, Oliveira LS, Bezerra LL, Neto JBA, Silva MMC, Cruz BG, Rocha JE, Barbosa CRS, da Silva AW, de Menezes JESA, Coutinho HDM, Marinho MM, Marinho ES, Dos Santos HS, Teixeira AMR. Anti-inflammatory effect, antibiotic potentiating activity against multidrug-resistant strains of Escherichia coli and Staphylococcus aureus, and evaluation of antibiotic resistance mechanisms by the ibuprofen derivative methyl 2-(-4-isobutylphenyl)propanoate. Microb Pathog 2022;170:105697. [PMID: 35926804 DOI: 10.1016/j.micpath.2022.105697] [Reference Citation Analysis]
28 de Castro Nobre AC, Pimentel CF, do Rêgo GMS, Paludo GR, Pereira Neto GB, de Castro MB, Nitz N, Hecht M, Dallago B, Hagström L. Insights from the use of erythropoietin in experimental Chagas disease. International Journal for Parasitology: Drugs and Drug Resistance 2022;19:65-80. [DOI: 10.1016/j.ijpddr.2022.05.005] [Reference Citation Analysis]
29 Haerkens F, Kikken C, Kirkels L, van Amstel M, Wouters W, van Doornmalen E, Francke C, Hughes S. A new use for old drugs: identifying compounds with an anti-obesity effect using a high through-put semi-automated Caenorhabditis elegans screening platform. Heliyon 2022;8:e10108. [PMID: 36033279 DOI: 10.1016/j.heliyon.2022.e10108] [Reference Citation Analysis]
30 Ayuso Muñoz A, Carro EU, Prieto Santamaría L, Carrasco BO, Ruiz EM, Pérez Gallardo Y, Rodríguez-gonzález A. REDIRECTION: Generating drug repurposing hypotheses using link prediction with DISNET data.. [DOI: 10.1101/2022.07.26.501105] [Reference Citation Analysis]
31 Sureja DK, Shah AP, Gajjar ND, Jadeja SB, Bodiwala KB, Dhameliya TM. In‐silico Computational Investigations of AntiViral Lignan Derivatives as Potent Inhibitors of SARS CoV‐2. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202202069] [Reference Citation Analysis]
32 Otero Carrasco B, Pérez Pérez A, Ruiz EM, Caraça-valente Hernández JP, Prieto Santamaría L, Rodríguez-gonzález A. Drug repositioning with gender perspective focused on Adverse Drug Reactions.. [DOI: 10.1101/2022.07.22.501091] [Reference Citation Analysis]
33 Pereira M, Matuszewska K, Glogova A, Petrik J. Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy. Cancers 2022;14:3500. [DOI: 10.3390/cancers14143500] [Reference Citation Analysis]
34 André Vannier-santos M, Márcia Suarez-fontes A, Almeida-silva J, Lifsitch Viçosa A, Aurora Chavez Perez S, Marcel Hasslocher-moreno A, Parreiras Estolano da Silveira G, Fernandes Portela L, Magalhães Saraiva R. Translational Research on Chagas Disease: Focusing on Drug Combination and Repositioning. Chagas Disease - From Cellular and Molecular Aspects of Trypanosoma cruzi-Host Interactions to the Clinical Intervention 2022. [DOI: 10.5772/intechopen.104231] [Reference Citation Analysis]
35 Dutta A. Predicting Drug Mechanics by Deep Learning on Gene and Cell Activities. 2022 44th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) 2022. [DOI: 10.1109/embc48229.2022.9871391] [Reference Citation Analysis]
36 Cavalcante BRR, Freitas RD, Siquara da Rocha LDO, Rocha GV, de Carvalho Pachêco TC, Pereira Ramos PI, Gurgel Rocha CA. In silico approaches for drug repurposing in oncology: Protocol for a scoping review of existing evidence. PLoS ONE 2022;17:e0271002. [DOI: 10.1371/journal.pone.0271002] [Reference Citation Analysis]
37 Czub N, Pacławski A, Szlęk J, Mendyk A. Do AutoML-Based QSAR Models Fulfill OECD Principles for Regulatory Assessment? A 5-HT1A Receptor Case. Pharmaceutics 2022;14:1415. [DOI: 10.3390/pharmaceutics14071415] [Reference Citation Analysis]
38 Munoz AA, Carro EU, Santamaria LP, Carrasco BO, Ruiz EM, Gallardo YP, Rodriguez-gonzalez A. REDIRECTION: Generating drug repurposing hypotheses using link prediction with DISNET data. 2022 IEEE 35th International Symposium on Computer-Based Medical Systems (CBMS) 2022. [DOI: 10.1109/cbms55023.2022.00009] [Reference Citation Analysis]
39 Carrasco BO, Perez AP, Ruiz EM, Hernandez JPC, Santamaria LP, Rodriguez-gonzalez A. Drug repositioning with gender perspective focused on Adverse Drug Reactions. 2022 IEEE 35th International Symposium on Computer-Based Medical Systems (CBMS) 2022. [DOI: 10.1109/cbms55023.2022.00084] [Reference Citation Analysis]
40 Tanner L, Bergwik J, Single AB, Bhongir RKV, Erjefält JS, Egesten A. Zoledronic Acid Targeting of the Mevalonate Pathway Causes Reduced Cell Recruitment and Attenuates Pulmonary Fibrosis. Front Pharmacol 2022;13:899469. [PMID: 35721132 DOI: 10.3389/fphar.2022.899469] [Reference Citation Analysis]
41 Lee C, Lin J, Prokop A, Gopalakrishnan V, Hanna RN, Papa E, Freeman A, Patel S, Yu W, Huhn M, Sheikh AS, Tan K, Sellman BR, Cohen T, Mangion J, Khan FM, Gusev Y, Shameer K. StarGazer: A Hybrid Intelligence Platform for Drug Target Prioritization and Digital Drug Repositioning Using Streamlit. Front Genet 2022;13:868015. [PMID: 35711912 DOI: 10.3389/fgene.2022.868015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Ribeiro JM, Rodrigues-Alves ML, Oliveira E, Guimarães PPG, Maria Murta Santi A, Teixeira-Carvalho A, Murta SMF, Peruhype-Magalhães V, Souza-Fagundes EM. Pamidronate, a promising repositioning drug to treat leishmaniasis, displays antileishmanial and immunomodulatory potential. Int Immunopharmacol 2022;110:108952. [PMID: 35716482 DOI: 10.1016/j.intimp.2022.108952] [Reference Citation Analysis]
43 Turabi KS, Deshmukh A, Paul S, Swami D, Siddiqui S, Kumar U, Naikar S, Devarajan S, Basu S, Paul MK, Aich J. Drug repurposing-an emerging strategy in cancer therapeutics. Naunyn Schmiedebergs Arch Pharmacol 2022. [PMID: 35695911 DOI: 10.1007/s00210-022-02263-x] [Reference Citation Analysis]
44 Motieghader H, Tabrizi-nezhadi P, Deldar Abad Paskeh M, Baradaran B, Mokhtarzadeh A, Hashemi M, Lanjanian H, Jazayeri SM, Maleki M, Khodadadi E, Nematzadeh S, Kiani F, Maghsoudloo M, Masoudi-nejad A. Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug–gene interaction networks analysis. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-13719-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Kim HA, Kim JE. Development of Nafamostat Mesylate Immediate-Release Tablet by Drug Repositioning Using Quality-by-Design Approach. Pharmaceutics 2022;14:1219. [PMID: 35745792 DOI: 10.3390/pharmaceutics14061219] [Reference Citation Analysis]
46 Majeed S, Mehraj S, Ahmad Z. Antituberculosis Drug Repurposing: A New Hope for Tackling Multi-Challenging TB in Timely Manner. Drug Repurposing - Molecular Aspects and Therapeutic Applications 2022. [DOI: 10.5772/intechopen.101642] [Reference Citation Analysis]
47 Zhang R, Oerlemans R, Wang C, Zhang L, R. Groves M. Drug Repurposing Techniques in Viral Diseases. Drug Repurposing - Molecular Aspects and Therapeutic Applications 2022. [DOI: 10.5772/intechopen.101443] [Reference Citation Analysis]
48 Meiners F, Secci R, Sueto S, Fuellen G, Barrantes I. Computational identification of natural senotherapeutic compounds that mimic dasatinib based on gene expression data.. [DOI: 10.1101/2022.05.26.492763] [Reference Citation Analysis]
49 Basu S, Shafi J. Topical Repute on Artificial Intelligence-Based Approaches in COVID-19 Supervision. Advances in Medical Technologies and Clinical Practice 2022. [DOI: 10.4018/978-1-6684-3791-9.ch008] [Reference Citation Analysis]
50 Lin W, Li L, Hsiao Y, Wong W, Chiu H, Hsu H, Peng Y, Ho C, Chernikov OV, Cheng S, Yang S, Hua K. Repositioning of the Angiotensin II Receptor Antagonist Candesartan as an Anti-Inflammatory Agent With NLRP3 Inflammasome Inhibitory Activity. Front Immunol 2022;13:870627. [DOI: 10.3389/fimmu.2022.870627] [Reference Citation Analysis]
51 Kaneko K, Miyasaka R, Hayman R. Nano-hydroxyapatite improves intestinal absorption of acetazolamide (BCS Class IV drug)–but how? PLoS ONE 2022;17:e0268067. [DOI: 10.1371/journal.pone.0268067] [Reference Citation Analysis]
52 Ko EA, Park YJ, Yoon DS, Lee KM, Kim J, Jung S, Lee JW, Park KH. Drug repositioning of polaprezinc for bone fracture healing. Commun Biol 2022;5:462. [PMID: 35577977 DOI: 10.1038/s42003-022-03424-7] [Reference Citation Analysis]
53 Liu S, Wang Y, Deng Y, He L, Shao B, Yin J, Zheng N, Liu TY, Wang T. Improved drug-target interaction prediction with intermolecular graph transformer. Brief Bioinform 2022:bbac162. [PMID: 35514186 DOI: 10.1093/bib/bbac162] [Reference Citation Analysis]
54 Wang G, Zhang X, Pan Z, Rodríguez Patón A, Wang S, Song T, Gu Y. Multi-TransDTI: Transformer for Drug–Target Interaction Prediction Based on Simple Universal Dictionaries with Multi-View Strategy. Biomolecules 2022;12:644. [DOI: 10.3390/biom12050644] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
55 El Zarif T, Yibirin M, De Oliveira-Gomes D, Machaalani M, Nawfal R, Bittar G, Bahmad HF, Bitar N. Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing. Cancers (Basel) 2022;14:2105. [PMID: 35565237 DOI: 10.3390/cancers14092105] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
56 Mifsud J, Cranswick N. Addressing the challenges of novel therapies in rare diseases with mechanistic perspectives: Missed opportunities or the way forward? Br J Clin Pharmacol 2022. [PMID: 35446442 DOI: 10.1111/bcp.15350] [Reference Citation Analysis]
57 Firoozbakht F, Rezaeian I, Rueda L, Ngom A. Computationally repurposing drugs for breast cancer subtypes using a network-based approach. BMC Bioinformatics 2022;23:143. [PMID: 35443626 DOI: 10.1186/s12859-022-04662-6] [Reference Citation Analysis]
58 Liu W, Wang G, Wang Z, Wang G, Huang J, Liu B. Repurposing small-molecule drugs for modulating toxic protein aggregates in neurodegenerative diseases. Drug Discov Today 2022:S1359-6446(22)00134-9. [PMID: 35395400 DOI: 10.1016/j.drudis.2022.04.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
59 Gu Y, Zheng S, Xu Z, Yin Q, Li L, Li J. An efficient curriculum learning-based strategy for molecular graph learning. Briefings in Bioinformatics. [DOI: 10.1093/bib/bbac099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 S H, G SS. A network based clustering approach for in silico drug repurposing in Alzheimer's Disease. 2022 8th International Conference on Advanced Computing and Communication Systems (ICACCS) 2022. [DOI: 10.1109/icaccs54159.2022.9785317] [Reference Citation Analysis]
61 Hamed AA, Fandy TE, Tkaczuk KL, Verspoor K, Lee BS. COVID-19 Drug Repurposing: A Network-Based Framework for Exploring Biomedical Literature and Clinical Trials for Possible Treatments. Pharmaceutics 2022;14:567. [DOI: 10.3390/pharmaceutics14030567] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Xie D, He S, Han L, Wu L, Huang H, Tao H, Zhou P, Shi X, Bai H, Bo X. Systematic optimization of host-directed therapeutic targets and preclinical validation of repositioned antiviral drugs. Brief Bioinform 2022:bbac047. [PMID: 35238349 DOI: 10.1093/bib/bbac047] [Reference Citation Analysis]
63 Roberti A, Chaffey LE, Greaves DR. NF-κB Signaling and Inflammation-Drug Repurposing to Treat Inflammatory Disorders? Biology (Basel) 2022;11:372. [PMID: 35336746 DOI: 10.3390/biology11030372] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
64 Giacomoni G. Towards a general framework for innovation shaped with AI to create and transform market offerings. European Management Review. [DOI: 10.1111/emre.12492] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
65 Zhang H, Cui H, Zhang T, Cao Y, Xuan P. Learning multi-scale heterogenous network topologies and various pairwise attributes for drug-disease association prediction. Brief Bioinform 2022:bbac009. [PMID: 35136910 DOI: 10.1093/bib/bbac009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Hua Y, Dai X, Xu Y, Xing G, Liu H, Lu T, Chen Y, Zhang Y. Drug repositioning: Progress and challenges in drug discovery for various diseases. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114239] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
67 Kobayashi Y, Takeda T, Kunitomi H, Chiwaki F, Komatsu M, Nagai S, Nogami Y, Tsuji K, Masuda K, Ogiwara H, Sasaki H, Banno K, Aoki D. Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian Cancer. Pharmaceuticals 2022;15:124. [DOI: 10.3390/ph15020124] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
68 Allahgholi M, Rahmani H, Javdani D, Sadeghi-adl Z, Bender A, Módos D, Weiss G. DDREL: From drug-drug relationships to drug repurposing. IDA 2022;26:221-37. [DOI: 10.3233/ida-215745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Riccio F, Micarelli E, Secci R, Giuliani G, Vumbaca S, Massacci G, Castagnoli L, Fuoco C, Cesareni G. Transcription Factor Activation Profiles (TFAP) identify compounds promoting differentiation of Acute Myeloid Leukemia cell lines. Cell Death Discov 2022;8:16. [PMID: 35013135 DOI: 10.1038/s41420-021-00811-7] [Reference Citation Analysis]
70 Ayyar P, Subramanian U. Repurposing – second life for drugs. PHAR 2022;69:51-9. [DOI: 10.3897/pharmacia.69.e72548] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Peng Y, Liu E, Peng S, Chen Q, Li D, Lian D. Using artificial intelligence technology to fight COVID-19: a review. Artif Intell Rev 2022;:1-37. [PMID: 35002010 DOI: 10.1007/s10462-021-10106-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
72 Wang Z, Yang B. Polypharmacology in Old Drug Rediscovery: Drug Repurposing. Polypharmacology 2022. [DOI: 10.1007/978-3-031-04998-9_13] [Reference Citation Analysis]
73 Kumar S. In Silico Drug Repositioning for COVID-19: Progress and Challenges. Frontiers of COVID-19 2022. [DOI: 10.1007/978-3-031-08045-6_24] [Reference Citation Analysis]
74 Lei P, Yuan C, Wu H, Zhao X. Drug–Target Interaction Prediction Based on Graph Neural Network and Recommendation System. Intelligent Computing Theories and Application 2022. [DOI: 10.1007/978-3-031-13829-4_6] [Reference Citation Analysis]
75 Pandita V, Parihar A, Parihar DS, Panda S, Shanmugarajan D, Kumari L, Badwaik HR. System and network biology-based computational approaches for drug repositioning. Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection 2022. [DOI: 10.1016/b978-0-323-91172-6.00003-0] [Reference Citation Analysis]
76 Dobreva J, Jovanovik M, Trajanov D. DD-RDL: Drug-Disease Relation Discovery and Labeling. Communications in Computer and Information Science 2022. [DOI: 10.1007/978-3-031-04206-5_8] [Reference Citation Analysis]
77 Wang Z, Yang B. Polypharmacology in Drug Design and Discovery—Basis for Rational Design of Multitarget Drugs. Polypharmacology 2022. [DOI: 10.1007/978-3-031-04998-9_12] [Reference Citation Analysis]
78 Farouk IA, Low ZY, Puniyamurti A, Zabidi NZ, Amin MKA, Lal SK. Genomic Approaches for Drug Repositioning. Biomedical Translational Research 2022. [DOI: 10.1007/978-981-16-9232-1_5] [Reference Citation Analysis]
79 Middha SK, Usha T, Sukhralia S, Pareek C, Yadav R, Agnihotri R, Tasneem J, Goyal AK, Babu D. Prediction of drug–target interaction —a helping hand in drug repurposing. Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection 2022. [DOI: 10.1016/b978-0-323-91172-6.00006-6] [Reference Citation Analysis]
80 Wang Z, Yang B. Strategies of Polypharmacology. Polypharmacology 2022. [DOI: 10.1007/978-3-031-04998-9_2] [Reference Citation Analysis]
81 Bustamante C, Muskus C, Ochoa R. Rational computational approaches to predict novel drug candidates against leishmaniasis. Annual Reports in Medicinal Chemistry 2022. [DOI: 10.1016/bs.armc.2022.08.005] [Reference Citation Analysis]
82 Aggarwal M, Mehta TA, Das A, Das A, Shruthi NR, Pathak S. Repurposing of Drug: Utility of Animal Models. Handbook of Animal Models and its Uses in Cancer Research 2022. [DOI: 10.1007/978-981-19-1282-5_8-1] [Reference Citation Analysis]
83 Kenmogne VL, Nweke EE, Takundwa MM, Fru PN, Thimiri Govinda Raj DB. Application of Drug Repurposing-Based Precision Medicine Platform for Leukaemia Patient Treatment. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/5584_2022_744] [Reference Citation Analysis]
84 Zhang M, Zhao B, Hu L, You Z, Chen Z. Predicting Drug-Disease Associations via Meta-path Representation Learning based on Heterogeneous Information Net works. Intelligent Computing Theories and Application 2022. [DOI: 10.1007/978-3-031-13829-4_18] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Gupta P, Bhachawat S, Dhyani K, Tripathy B. A Study of Gene Characteristics and Their Applications Using Deep Learning. Studies in Big Data 2022. [DOI: 10.1007/978-981-16-9158-4_4] [Reference Citation Analysis]
86 Markowicz-Piasecka M, Huttunen J, Zajda A, Sikora J, Huttunen KM. Sulfonamide metformin derivatives induce mitochondrial-associated apoptosis and cell cycle arrest in breast cancer cells. Chem Biol Interact 2021;352:109795. [PMID: 34953865 DOI: 10.1016/j.cbi.2021.109795] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
87 Choi BY, Han M, Kwak JW, Kim TH. Genetics and Epigenetics in Allergic Rhinitis. Genes (Basel) 2021;12:2004. [PMID: 34946955 DOI: 10.3390/genes12122004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
88 Ciarpella F, Zamfir RG, Campanelli A, Ren E, Pedrotti G, Bottani E, Borioli A, Caron D, Di Chio M, Dolci S, Ahtiainen A, Malpeli G, Malerba G, Bardoni R, Fumagalli G, Hyttinen J, Bifari F, Palazzolo G, Panuccio G, Curia G, Decimo I. Murine cerebral organoids develop network of functional neurons and hippocampal brain region identity. iScience 2021;24:103438. [PMID: 34901791 DOI: 10.1016/j.isci.2021.103438] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
89 Jain H, Bhat AR, Dalvi H, Godugu C, Singh SB, Srivastava S. Repurposing approved therapeutics for new indication: Addressing unmet needs in psoriasis treatment. Curr Res Pharmacol Drug Discov 2021;2:100041. [PMID: 34909670 DOI: 10.1016/j.crphar.2021.100041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
90 Cetin-Atalay R, Kahraman DC, Nalbat E, Rifaioglu AS, Atakan A, Donmez A, Atas H, Atalay MV, Acar AC, Doğan T. Data Centric Molecular Analysis and Evaluation of Hepatocellular Carcinoma Therapeutics Using Machine Intelligence-Based Tools. J Gastrointest Cancer 2021. [PMID: 34910274 DOI: 10.1007/s12029-021-00768-x] [Reference Citation Analysis]
91 Oso BJ, Ogidi CO. Repositioning of Fungal-based Peptides as Modulators of Angiotensin-converting Enzyme-related Carboxypeptidase, SARS-coronavirus HR2 Domain, and Coronavirus Disease 2019 Main Protease. J Transl Int Med 2021;9:190-9. [PMID: 34900630 DOI: 10.2478/jtim-2021-0038] [Reference Citation Analysis]
92 Al-Taie Z, Hannink M, Mitchem J, Papageorgiou C, Shyu CR. Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer. Cancers (Basel) 2021;13:6278. [PMID: 34944904 DOI: 10.3390/cancers13246278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Groza V, Udrescu M, Bozdog A, Udrescu L. Drug Repurposing Using Modularity Clustering in Drug-Drug Similarity Networks Based on Drug-Gene Interactions. Pharmaceutics 2021;13:2117. [PMID: 34959398 DOI: 10.3390/pharmaceutics13122117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
94 Soltan OM, Shoman ME, Abdel-Aziz SA, Narumi A, Konno H, Abdel-Aziz M. Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy. Eur J Med Chem 2021;225:113768. [PMID: 34450497 DOI: 10.1016/j.ejmech.2021.113768] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
95 Martínez-deMiguel C, Segura-Bedmar I, Chacón-Solano E, Guerrero-Aspizua S. The RareDis corpus: A corpus annotated with rare diseases, their signs and symptoms. J Biomed Inform 2021;125:103961. [PMID: 34879250 DOI: 10.1016/j.jbi.2021.103961] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
96 Martín-Escolano R, Yiangou L, Kazana E, Robinson GK, Michaelis M, Tsaousis AD. Repurposing in vitro approaches for screening anti-parasitic drugs against the brain-eating amoeba Naegleria fowleri. Int J Parasitol Drugs Drug Resist 2021;17:204-12. [PMID: 34875573 DOI: 10.1016/j.ijpddr.2021.10.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Lata S, Siddharth. Sustainable and eco-friendly approach for controlling industrial wastewater quality imparting succour in water-energy nexus system. Energy Nexus 2021;3:100020. [DOI: 10.1016/j.nexus.2021.100020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
98 Tanner L, Bergwik J, Bhongir RK, Egesten A. Zoledronic acid targets the mevalonate pathway causing reduced cell recruitment and attenuation of pulmonary fibrosis.. [DOI: 10.1101/2021.12.01.470755] [Reference Citation Analysis]
99 ElHarouni D, Berker Y, Peterziel H, Gopisetty A, Turunen L, Kreth S, Stainczyk SA, Oehme I, Pietiäinen V, Jäger N, Witt O, Schlesner M, Oppermann S. iTReX: Interactive exploration of mono- and combination therapy dose response profiling data. Pharmacol Res 2021;175:105996. [PMID: 34848323 DOI: 10.1016/j.phrs.2021.105996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
100 Cho H, Kim N, Murakami T, Sim T. Anti-Tumor Activity of AZD4547 Against NTRK1 Fusion Positive Cancer Cells Through Inhibition of NTRKs. Front Oncol 2021;11:757598. [PMID: 34790577 DOI: 10.3389/fonc.2021.757598] [Reference Citation Analysis]
101 Kumbhar P, Manjappa A, Shah R, Jha NK, Singh SK, Dua K, Disouza J, Patravale V. Inhalation delivery of repurposed drugs for lung cancer: Approaches, benefits and challenges. J Control Release 2021;341:1-15. [PMID: 34780880 DOI: 10.1016/j.jconrel.2021.11.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
102 Rangel-Castañeda IA, Castillo-Romero A, León-Ávila G, Zermeño-Ruiz M, Hernández-Hernández JM. Drug repositioning: antiprotozoal activity of terfenadine against Entamoeba histolytica trophozoites. Parasitol Res 2021. [PMID: 34741218 DOI: 10.1007/s00436-021-07354-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Adikusuma W, Irham LM, Chou WH, Wong HS, Mugiyanto E, Ting J, Perwitasari DA, Chang WP, Chang WC. Drug Repurposing for Atopic Dermatitis by Integration of Gene Networking and Genomic Information. Front Immunol 2021;12:724277. [PMID: 34721386 DOI: 10.3389/fimmu.2021.724277] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
104 Jung YS, Kim Y, Cho YR. Comparative analysis of network-based approaches and machine learning algorithms for predicting drug-target interactions. Methods 2021:S1046-2023(21)00247-4. [PMID: 34737033 DOI: 10.1016/j.ymeth.2021.10.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
105 Santos JMO, Costa AC, Dias TR, Satari S, Costa E Silva MP, da Costa RMG, Medeiros R. Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates. Pharmaceuticals (Basel) 2021;14:1084. [PMID: 34832866 DOI: 10.3390/ph14111084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Usman A, Khan FF. Identification of antineoplastic agents for oral squamous cell carcinoma: an integrated bioinformatics approach using differential gene expression and network biology.. [DOI: 10.1101/2021.10.14.464376] [Reference Citation Analysis]
107 Puzari U, Fernandes PA, Mukherjee AK. Advances in the Therapeutic Application of Small-Molecule Inhibitors and Repurposed Drugs against Snakebite. J Med Chem 2021;64:13938-79. [PMID: 34565143 DOI: 10.1021/acs.jmedchem.1c00266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Madugula SS, John L, Nagamani S, Gaur AS, Poroikov VV, Sastry GN. Molecular descriptor analysis of approved drugs using unsupervised learning for drug repurposing. Comput Biol Med 2021;138:104856. [PMID: 34555571 DOI: 10.1016/j.compbiomed.2021.104856] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
109 Tieu JH, Sahasrabudhe SA, Orchard PJ, Cloyd JC, Kartha RV. Translational and clinical pharmacology considerations in drug repurposing for X-linked adrenoleukodystrophy-A rare peroxisomal disorder. Br J Clin Pharmacol 2021. [PMID: 34558098 DOI: 10.1111/bcp.15090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Leggas D, Baskaran M, Ezick J, von Hofe B. Filtered Tensor Construction and Decomposition for Drug Repositioning. 2021 IEEE High Performance Extreme Computing Conference (HPEC) 2021. [DOI: 10.1109/hpec49654.2021.9622827] [Reference Citation Analysis]
111 Beklen H, Arslan S, Gulfidan G, Turanli B, Ozbek P, Karademir Yilmaz B, Arga KY. Differential Interactome Based Drug Repositioning Unraveled Abacavir, Exemestane, Nortriptyline Hydrochloride, and Tolcapone as Potential Therapeutics for Colorectal Cancers. Front Bioinform 2021;1. [DOI: 10.3389/fbinf.2021.710591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Kang H, Lee S, Kim K, Jeon J, Kang SG, Youn H, Kim HY, Youn B. Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma. J Exp Clin Cancer Res 2021;40:282. [PMID: 34488821 DOI: 10.1186/s13046-021-02077-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
113 Luo L, Qiu Q, Huang F, Liu K, Lan Y, Li X, Huang Y, Cui L, Luo H. Drug repurposing against coronavirus disease 2019 (COVID-19): A review. J Pharm Anal 2021. [PMID: 34513115 DOI: 10.1016/j.jpha.2021.09.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
114 Li Y, Qiao G, Wang K, Wang G. Drug-target interaction predication via multi-channel graph neural networks. Brief Bioinform 2021:bbab346. [PMID: 34661237 DOI: 10.1093/bib/bbab346] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
115 Prieto Santamaría L, Ugarte Carro E, Díaz Uzquiano M, Menasalvas Ruiz E, Pérez Gallardo Y, Rodríguez-González A. A data-driven methodology towards evaluating the potential of drug repurposing hypotheses. Comput Struct Biotechnol J 2021;19:4559-73. [PMID: 34471499 DOI: 10.1016/j.csbj.2021.08.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 10.0] [Reference Citation Analysis]
116 Hayden MR. Hypothesis: Neuroglia Activation Due to Increased Peripheral and CNS Proinflammatory Cytokines/Chemokines with Neuroinflammation May Result in Long COVID. Neuroglia 2021;2:7-35. [DOI: 10.3390/neuroglia2010004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
117 Chadaga K, Prabhu S, Vivekananda BK, Niranjana S, Umakanth S, Pham DT. Battling COVID-19 using machine learning: A review. Cogent Engineering 2021;8:1958666. [DOI: 10.1080/23311916.2021.1958666] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
118 Rausch M, Rutz A, Allard PM, Delucinge-Vivier C, Docquier M, Dormond O, Dyson PJ, Wolfender JL, Nowak-Sliwinska P. Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma. Cancers (Basel) 2021;13:3978. [PMID: 34439134 DOI: 10.3390/cancers13163978] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
119 Pan Y, Lei X, Zhang Y. Association predictions of genomics, proteinomics, transcriptomics, microbiome, metabolomics, pathomics, radiomics, drug, symptoms, environment factor, and disease networks: A comprehensive approach. Med Res Rev 2021. [PMID: 34346083 DOI: 10.1002/med.21847] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
120 Rahman F, Libre C, Oleinikov A, Tcherniuk S. Chloroquine and pyrimethamine inhibit the replication of human respiratory syncytial virus A. J Gen Virol 2021;102. [PMID: 34342560 DOI: 10.1099/jgv.0.001627] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
121 Son J, Lee SY. Emetine exerts anticancer effects in U2OS human osteosarcoma cells via activation of p38 and inhibition of ERK, JNK, and β-catenin signaling pathways. J Biochem Mol Toxicol 2021;:e22868. [PMID: 34338395 DOI: 10.1002/jbt.22868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
122 Mohammad Sadeghi H, Adeli I, Mousavi T, Daniali M, Nikfar S, Abdollahi M. Drug Repurposing for the Management of Depression: Where Do We Stand Currently? Life (Basel) 2021;11:774. [PMID: 34440518 DOI: 10.3390/life11080774] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
123 Challa AP, Zaleski NM, Jerome RN, Lavieri RR, Shirey-Rice JK, Barnado A, Lindsell CJ, Aronoff DM, Crofford LJ, Harris RC, Alp Ikizler T, Mayer IA, Holroyd KJ, Pulley JM. Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases. Front Genet 2021;12:707836. [PMID: 34394194 DOI: 10.3389/fgene.2021.707836] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
124 Ni Ki C, Hosseinian‐far A, Daneshkhah A, Salari N. Topic modelling in precision medicine with its applications in personalized diabetes management. Expert Systems. [DOI: 10.1111/exsy.12774] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
125 Beklen H, Yildirim E, Kori M, Turanli B, Arga KY. Systems-level biomarkers identification and drug repositioning in colorectal cancer. WJGO 2021;13:463-86. [DOI: 10.4251/wjgo.v13.i7.463] [Reference Citation Analysis]
126 Beklen H, Yildirim E, Kori M, Turanli B, Arga KY. Systems-level biomarkers identification and drug repositioning in colorectal cancer. World J Gastrointest Oncol 2021; 13(7): 638-661 [PMID: 34322194 DOI: 10.4251/wjgo.v13.i7.638] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
127 Sadeghi SS, Keyvanpour MR. Computational Drug Repurposing: Classification of the Research Opportunities and Challenges. Curr Comput Aided Drug Des 2020;16:354-64. [PMID: 31198115 DOI: 10.2174/1573409915666190613113822] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
128 Jhanji R, Singh A, Kumar A. Antibacterial potential of selected phytomolecules: An experimental study. Microbiol Immunol 2021;65:325-32. [PMID: 33930208 DOI: 10.1111/1348-0421.12890] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
129 Gopal J, Prakash Sinnarasan VS, Venkatesan A. Identification of Repurpose Drugs by Computational Analysis of Disease-Gene-Drug Associations. J Comput Biol 2021;28:975-84. [PMID: 34242526 DOI: 10.1089/cmb.2020.0356] [Reference Citation Analysis]
130 Mavridou D, Psatha K, Aivaliotis M. Proteomics and Drug Repurposing in CLL towards Precision Medicine. Cancers (Basel) 2021;13:3391. [PMID: 34298607 DOI: 10.3390/cancers13143391] [Reference Citation Analysis]
131 Hirata N, Yamada S, Yanagida S, Ono A, Kanda Y. FTY720 Inhibits Expansion of Breast Cancer Stem Cells via PP2A Activation. Int J Mol Sci 2021;22:7259. [PMID: 34298877 DOI: 10.3390/ijms22147259] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
132 Gao H, Ni Y, Mo X, Li D, Teng S, Huang Q, Huang S, Liu G, Zhang S, Tang Y, Lu L, Liang H. Drug repositioning based on network-specific core genes identifies potential drugs for the treatment of autism spectrum disorder in children. Comput Struct Biotechnol J 2021;19:3908-21. [PMID: 34306572 DOI: 10.1016/j.csbj.2021.06.046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Sadovnikova IS, Gureev AP, Ignatyeva DA, Gryaznova MV, Chernyshova EV, Krutskikh EP, Novikova AG, Popov VN. Nrf2/ARE Activators Improve Memory in Aged Mice via Maintaining of Mitochondrial Quality Control of Brain and the Modulation of Gut Microbiome. Pharmaceuticals (Basel) 2021;14:607. [PMID: 34201885 DOI: 10.3390/ph14070607] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
134 Riccio F, Micarelli E, Secci R, Giuliani G, Vumbaca S, Massacci G, Castagnoli L, Fuoco C, Cesareni G. Transcription Factor Activation Profiles (TFAP) identify compounds promoting differentiation of Acute Myeloid Leukemia cell lines.. [DOI: 10.1101/2021.06.22.449489] [Reference Citation Analysis]
135 Lim J, Kim HI, Bang Y, Choi HJ. Peroxisome proliferator-activated receptor gamma: a novel therapeutic target for cognitive impairment and mood disorders that functions via the regulation of adult neurogenesis. Arch Pharm Res 2021;44:553-63. [PMID: 34138417 DOI: 10.1007/s12272-021-01333-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
136 Somolinos FJ, León C, Guerrero-aspizua S. Drug Repurposing Using Biological Networks. Processes 2021;9:1057. [DOI: 10.3390/pr9061057] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
137 Vlachakis D, Vlamos P. Mathematical Multidimensional Modelling and Structural Artificial Intelligence Pipelines Provide Insights for the Designing of Highly Specific AntiSARS-CoV2 Agents. Math Comput Sci 2021;15:877-88. [DOI: 10.1007/s11786-021-00517-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
138 Surianarayanan C, Chelliah PR. Leveraging Artificial Intelligence (AI) Capabilities for COVID-19 Containment. New Gener Comput 2021;:1-25. [PMID: 34131359 DOI: 10.1007/s00354-021-00128-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
139 Tripathi N, Goshisht MK, Sahu SK, Arora C. Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive review. Mol Divers 2021;25:1643-64. [PMID: 34110579 DOI: 10.1007/s11030-021-10237-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
140 Muramatsu T, Tanokura M. A novel method of literature mining to identify candidate COVID-19 drugs. Bioinformatics Advances 2021;1. [DOI: 10.1093/bioadv/vbab013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
141 Noh M, Zhang H, Kim H, Park S, Kim YM, Kwon YG. Primaquine Diphosphate, a Known Antimalarial Drug, Blocks Vascular Leakage Acting Through Junction Stabilization. Front Pharmacol 2021;12:695009. [PMID: 34149436 DOI: 10.3389/fphar.2021.695009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Advani D, Kumar P. Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer's Disease: Using the Multiomics Approach. ACS Omega 2021;6:13870-87. [PMID: 34095679 DOI: 10.1021/acsomega.1c01526] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
143 Nehdi A, Samman N, Mashhour A, Alhallaj A, Trivilegio T, Gul S, Reinshagen J, Alaskar A, Gmati G, Abuelgasim KA, Mansour F, Boudjelal M. A Drug Repositioning Approach Identifies a Combination of Compounds as a Potential Regimen for Chronic Lymphocytic Leukemia Treatment. Front Oncol 2021;11:579488. [PMID: 34123769 DOI: 10.3389/fonc.2021.579488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
144 Sarhan AA, Ashour NA, Al-Karmalawy AA. The journey of antimalarial drugs against SARS-CoV-2: Review article. Inform Med Unlocked 2021;24:100604. [PMID: 34028468 DOI: 10.1016/j.imu.2021.100604] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
145 Lucchetta M, Pellegrini M. Drug Repositioning by Merging Active Subnetworks Validated in Cancer and COVID-19.. [DOI: 10.1101/2021.05.13.21257140] [Reference Citation Analysis]
146 Avti P, Chauhan A, Shekhar N, Prajapat M, Sarma P, Kaur H, Bhattacharyya A, Kumar S, Prakash A, Sharma S, Medhi B. Computational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findings. J Biomol Struct Dyn 2021;:1-11. [PMID: 33998950 DOI: 10.1080/07391102.2021.1922310] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
147 Dimitrova M, Meyer R, Buttigieg PL, Georgiev T, Zhelezov G, Demirov S, Smith V, Penev L. A streamlined workflow for conversion, peer review, and publication of genomics metadata as omics data papers. Gigascience 2021;10:giab034. [PMID: 33983435 DOI: 10.1093/gigascience/giab034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
148 Yazdani M, Khezri J, Hadizadeh N, Amir Zakaria JZ, Naderi M, Mahmoodian S, Karkhanei AA, Razi F, Sanati MH, Hashemi E. Depinar, a drug that potentially inhibits the binding and entry of COVID-19 into host cells based on computer-aided studies. Res Pharm Sci 2021;16:315-25. [PMID: 34221065 DOI: 10.4103/1735-5362.314830] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
149 Kim Q, Ko JH, Kim S, Park N, Jhe W. Bayesian neural network with pretrained protein embedding enhances prediction accuracy of drug-protein interaction. Bioinformatics 2021:btab346. [PMID: 33978713 DOI: 10.1093/bioinformatics/btab346] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
150 Iswahyuli, Bustamam A, Yanuar A, Mangunwardoyo W. One-Dimensional Convolutional Neural Network Method as The Predicting Model for Interactions Between Drug and Protein on Heterogeneous Network. 2021 International Conference on Artificial Intelligence and Mechatronics Systems (AIMS) 2021. [DOI: 10.1109/aims52415.2021.9466059] [Reference Citation Analysis]
151 Zhao BW, You ZH, Hu L, Guo ZH, Wang L, Chen ZH, Wong L. A Novel Method to Predict Drug-Target Interactions Based on Large-Scale Graph Representation Learning. Cancers (Basel) 2021;13:2111. [PMID: 33925568 DOI: 10.3390/cancers13092111] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
152 Al-Taie Z, Liu D, Mitchem JB, Papageorgiou C, Kaifi JT, Warren WC, Shyu CR. Explainable artificial intelligence in high-throughput drug repositioning for subgroup stratifications with interventionable potential. J Biomed Inform 2021;118:103792. [PMID: 33915273 DOI: 10.1016/j.jbi.2021.103792] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
153 Alavi SE, Ebrahimi Shahmabadi H. Anthelmintics for drug repurposing: Opportunities and challenges. Saudi Pharm J 2021;29:434-45. [PMID: 34135669 DOI: 10.1016/j.jsps.2021.04.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
154 Dotolo S, Marabotti A, Facchiano A, Tagliaferri R. A review on drug repurposing applicable to COVID-19. Brief Bioinform 2021;22:726-41. [PMID: 33147623 DOI: 10.1093/bib/bbaa288] [Cited by in Crossref: 67] [Cited by in F6Publishing: 79] [Article Influence: 67.0] [Reference Citation Analysis]
155 Abbas K, Abbasi A, Dong S, Niu L, Yu L, Chen B, Cai SM, Hasan Q. Application of network link prediction in drug discovery. BMC Bioinformatics 2021;22:187. [PMID: 33845763 DOI: 10.1186/s12859-021-04082-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
156 Jeong SM, Yoon TJ. Development of Pigmentation-Regulating Agents by Drug Repositioning. Int J Mol Sci 2021;22:3894. [PMID: 33918792 DOI: 10.3390/ijms22083894] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
157 Zhao BW, You ZH, Wong L, Zhang P, Li HY, Wang L. MGRL: Predicting Drug-Disease Associations Based on Multi-Graph Representation Learning. Front Genet 2021;12:657182. [PMID: 34054920 DOI: 10.3389/fgene.2021.657182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
158 Rabben HL, Andersen GT, Ianevski A, Olsen MK, Kainov D, Grønbech JE, Wang TC, Chen D, Zhao CM. Computational Drug Repositioning and Experimental Validation of Ivermectin in Treatment of Gastric Cancer. Front Pharmacol 2021;12:625991. [PMID: 33867984 DOI: 10.3389/fphar.2021.625991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Yoshida GJ, Saya H. Molecular pathology underlying the robustness of cancer stem cells. Regen Ther 2021;17:38-50. [PMID: 33869685 DOI: 10.1016/j.reth.2021.02.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
160 Fiscon G, Paci P. SAveRUNNER: an R-based tool for drug repurposing. BMC Bioinformatics 2021;22:150. [PMID: 33757425 DOI: 10.1186/s12859-021-04076-w] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 20.0] [Reference Citation Analysis]
161 Zhang G, Gao Z, Zhang Y, Yan C, Wang J. Drug Repositioning Method Based on Deep Neural Network. 2021 IEEE International Conference on Information Communication and Software Engineering (ICICSE) 2021. [DOI: 10.1109/icicse52190.2021.9404136] [Reference Citation Analysis]
162 Sahoo BM, Ravi Kumar BVV, Sruti J, Mahapatra MK, Banik BK, Borah P. Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection. Front Mol Biosci 2021;8:628144. [PMID: 33718434 DOI: 10.3389/fmolb.2021.628144] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 17.0] [Reference Citation Analysis]
163 Veschi S, Carradori S, De Lellis L, Florio R, Brocco D, Secci D, Guglielmi P, Spano M, Sobolev AP, Cama A. Synthesis and evaluation of a large library of nitroxoline derivatives as pancreatic cancer antiproliferative agents. J Enzyme Inhib Med Chem 2020;35:1331-44. [PMID: 32588672 DOI: 10.1080/14756366.2020.1780228] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
164 Foletto VS, da Rosa TF, Serafin MB, Bottega A, Franco LN, de Paula BR, Hörner R. Repositioning of antidepressant drugs and synergistic effect with ciprofloxacin against multidrug-resistant bacteria. World J Microbiol Biotechnol 2021;37:53. [PMID: 33604693 DOI: 10.1007/s11274-021-03016-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
165 Fiscon G, Conte F, Farina L, Paci P. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19. PLoS Comput Biol 2021;17:e1008686. [PMID: 33544720 DOI: 10.1371/journal.pcbi.1008686] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 43.0] [Reference Citation Analysis]
166 Magavern EF, Kaski JC, Turner RM, Janmohamed A, Borry P, Pirmohamed M. The Interface of Therapeutics and Genomics in Cardiovascular Medicine. Cardiovasc Drugs Ther 2021;35:663-76. [PMID: 33528719 DOI: 10.1007/s10557-021-07149-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
167 Mohapatra TK, Moharana AK, Swain RP, Subudhi B. Coamorphisation of acetyl salicylic acid and curcumin for enhancing dissolution, anti-inflammatory effect and minimizing gastro toxicity. Journal of Drug Delivery Science and Technology 2021;61:102119. [DOI: 10.1016/j.jddst.2020.102119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
168 Alafif T, Tehame AM, Bajaba S, Barnawi A, Zia S. Machine and Deep Learning towards COVID-19 Diagnosis and Treatment: Survey, Challenges, and Future Directions. Int J Environ Res Public Health 2021;18:1117. [PMID: 33513984 DOI: 10.3390/ijerph18031117] [Cited by in Crossref: 44] [Cited by in F6Publishing: 51] [Article Influence: 44.0] [Reference Citation Analysis]
169 Gallo K, Goede A, Eckert A, Moahamed B, Preissner R, Gohlke BO. PROMISCUOUS 2.0: a resource for drug-repositioning. Nucleic Acids Res 2021;49:D1373-80. [PMID: 33196798 DOI: 10.1093/nar/gkaa1061] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
170 Rimpelová S, Zimmermann T, Drašar PB, Dolenský B, Bejček J, Kmoníčková E, Cihlářová P, Gurská S, Kuklíková L, Hajdůch M, Ruml T, Opletal L, Džubák P, Jurášek M. Steroid Glycosides Hyrcanoside and Deglucohyrcanoside: On Isolation, Structural Identification, and Anticancer Activity. Foods 2021;10:136. [PMID: 33440629 DOI: 10.3390/foods10010136] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
171 Zhang X, Che C. Drug Repurposing for Parkinson’s Disease by Integrating Knowledge Graph Completion Model and Knowledge Fusion of Medical Literature. Future Internet 2021;13:14. [DOI: 10.3390/fi13010014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
172 Che M, Yao K, Che C, Cao Z, Kong F. Knowledge-Graph-Based Drug Repositioning against COVID-19 by Graph Convolutional Network with Attention Mechanism. Future Internet 2021;13:13. [DOI: 10.3390/fi13010013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
173 Zhou X, Wang N, Zhai X. Common Network Pharmacology Software. Network Pharmacology 2021. [DOI: 10.1007/978-981-16-0753-0_4] [Reference Citation Analysis]
174 Ciarpella F, Zamfir RG, Campanelli A, Ren E, Pedrotti G, Bottani E, Caron D, Di Chio M, Dolci S, Ahtiainen A, Malpeli G, Malerba G, Bardoni R, Fumagalli G, Hyttinen J, Bifari F, Palazzolo G, Panuccio G, Curia G, Decimo I. Development of Robust and Reproducible Murine Brain Organoids Endowed With Networks of Functional Neurons and Specific Brain-Region Signature. SSRN Journal. [DOI: 10.2139/ssrn.3867731] [Reference Citation Analysis]
175 Ivan M, Jozef Č, Gustáv K, Mária P, Lucia H. Triazavirin might be the new hope to fight Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). CSF 2021;70:18-25. [DOI: 10.5817/csf2021-1-18] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Lakizadeh A, Hassan Mir-ashrafi SM. Drug repurposing improvement using a novel data integration framework based on the drug side effect. Informatics in Medicine Unlocked 2021;23:100523. [DOI: 10.1016/j.imu.2021.100523] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
177 Shakyawar SK, Sethi S, Southekal S, Mishra NK, Guda C. Big Data Analytics for Modeling COVID-19 and Comorbidities: An Unmet Need. EAI/Springer Innovations in Communication and Computing 2021. [DOI: 10.1007/978-3-030-68936-0_10] [Reference Citation Analysis]
178 Deepthi K, Jereesh AS. Drug Repositioning Based on Heterogeneous Network Inference. Advances in Intelligent Systems and Computing 2021. [DOI: 10.1007/978-981-15-5113-0_96] [Reference Citation Analysis]
179 Floresta G, Crocetti L, Giovannoni MP, Biagini P, Cilibrizzi A. Repurposing strategies on pyridazinone-based series by pharmacophore- and structure-driven screening. J Enzyme Inhib Med Chem 2020;35:1137-44. [PMID: 32367744 DOI: 10.1080/14756366.2020.1760261] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
180 Abdella M, Abdella B, Lahiri C. Rediscovering and repurposing natural microbial macromolecules through computational approaches. Microbial and Natural Macromolecules 2021. [DOI: 10.1016/b978-0-12-820084-1.00016-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
181 Roy SN, Mishra S, Yusof SM. Emergence of Drug Discovery in Machine Learning. Technical Advancements of Machine Learning in Healthcare 2021. [DOI: 10.1007/978-981-33-4698-7_7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
182 Balandrán-quintana RR, Mendoza-wilson AM, Ramos-clamont Montfort G, Huerta-ocampo JÁ, Mazorra-manzano MA. Peptides and Proteins. Food Bioactives and Health 2021. [DOI: 10.1007/978-3-030-57469-7_3] [Reference Citation Analysis]
183 Ashenden SK, Kurbatova N, Bartosik A. Target identification and validation. The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry 2021. [DOI: 10.1016/b978-0-12-820045-2.00005-2] [Reference Citation Analysis]
184 Ganguli R. Machine Learning Application in COVID-19 Drug Development. Medical Virology: From Pathogenesis to Disease Control 2021. [DOI: 10.1007/978-981-15-7317-0_12] [Reference Citation Analysis]
185 Xie N, Huang C. Drug Repurposing: An Avenue Toward Stress Medicine in Cancer Therapy. Oxidative Stress 2021. [DOI: 10.1007/978-981-16-0522-2_10] [Reference Citation Analysis]
186 Badkas A, De Landtsheer S, Sauter T. Topological network measures for drug repositioning. Brief Bioinform 2021;22:bbaa357. [PMID: 33348366 DOI: 10.1093/bib/bbaa357] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
187 Giorgio E, Pesce E, Pozzi E, Sondo E, Ferrero M, Morerio C, Borrelli G, Della Sala E, Lorenzati M, Cortelli P, Buffo A, Pedemonte N, Brusco A. A high-content drug screening strategy to identify protein level modulators for genetic diseases: A proof-of-principle in autosomal dominant leukodystrophy. Hum Mutat 2021;42:102-16. [PMID: 33252173 DOI: 10.1002/humu.24147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
188 Vivarelli S, Candido S, Caruso G, Falzone L, Libra M. Patient-Derived Tumor Organoids for Drug Repositioning in Cancer Care: A Promising Approach in the Era of Tailored Treatment. Cancers (Basel) 2020;12:E3636. [PMID: 33291603 DOI: 10.3390/cancers12123636] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
189 Rudrapal M, J. Khairnar S, G. Jadhav A. Drug Repurposing (DR): An Emerging Approach in Drug Discovery. Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications 2020. [DOI: 10.5772/intechopen.93193] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 14.5] [Reference Citation Analysis]
190 Dhir N, Jain A, Mahendru D, Prakash A, Medhi B. Drug Repurposing and Orphan Disease Therapeutics. Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications 2020. [DOI: 10.5772/intechopen.91941] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
191 Arora S, Lohiya G, Moharir K, Shah S, Yende S. Identification of Potential Flavonoid Inhibitors of the SARS-CoV-2 Main Protease 6YNQ: A Molecular Docking Study. Digital Chinese Medicine 2020;3:239-48. [DOI: 10.1016/j.dcmed.2020.12.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
192 Ramírez-Salinas GL, Martínez-Archundia M, Correa-Basurto J, García-Machorro J. Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study. Molecules 2020;25:E5615. [PMID: 33260370 DOI: 10.3390/molecules25235615] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
193 Krishnamoorthy P, Raj AS, Roy S, Kumar NS, Kumar H. Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing. Comput Biol Med 2021;128:104123. [PMID: 33260034 DOI: 10.1016/j.compbiomed.2020.104123] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
194 Cabrera-Andrade A, López-Cortés A, Jaramillo-Koupermann G, González-Díaz H, Pazos A, Munteanu CR, Pérez-Castillo Y, Tejera E. A Multi-Objective Approach for Anti-Osteosarcoma Cancer Agents Discovery through Drug Repurposing. Pharmaceuticals (Basel) 2020;13:E409. [PMID: 33266378 DOI: 10.3390/ph13110409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
195 Silva VR, Neves SP, Santos LS, Dias RB, Bezerra DP. Challenges and Therapeutic Opportunities of Autophagy in Cancer Therapy. Cancers (Basel) 2020;12:E3461. [PMID: 33233671 DOI: 10.3390/cancers12113461] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
196 Juárez-López D, Schcolnik-Cabrera A. Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments. Arch Med Res 2021;52:243-51. [PMID: 33190955 DOI: 10.1016/j.arcmed.2020.10.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
197 Machado CB, Rocha da Silva C, Daiana Barroso F, Campos RDS, Valente Sá LGDA, S Aires do Nascimento FB, Cavalcanti BC, Vitoriano Nobre Júnior H, Andrade Neto JB. In vitro evaluation of anti-fungal activity of tropicamide against strains of Candida spp. resistant to fluconazole in planktonic and biofilm form. J Mycol Med 2021;31:101080. [PMID: 33278803 DOI: 10.1016/j.mycmed.2020.101080] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
198 Cüvitoğlu A, Işik Z. Akciğer ve Prostat Kanseri için İlaç Yeniden Konumlandırmanın Uygulanması. European Journal of Science and Technology 2020. [DOI: 10.31590/ejosat.823405] [Reference Citation Analysis]
199 Huang L, Luo H, Li S, Wu FX, Wang J. Drug-drug similarity measure and its applications. Brief Bioinform 2021;22:bbaa265. [PMID: 33152756 DOI: 10.1093/bib/bbaa265] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
200 Shanmugam A, Muralidharan N, Velmurugan D, Gromiha MM. Therapeutic Targets and Computational Approaches on Drug Development for COVID-19. CTMC 2020;20:2210-20. [DOI: 10.2174/1568026620666200710105507] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
201 Ghosh R, Chakraborty A, Biswas A, Chowdhuri S. Potential therapeutic use of corticosteroids as SARS CoV-2 main protease inhibitors: a computational study. J Biomol Struct Dyn 2020;:1-14. [PMID: 33094701 DOI: 10.1080/07391102.2020.1835728] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
202 Trajanoska K, Rivadeneira F. Genomic Medicine: Lessons Learned From Monogenic and Complex Bone Disorders. Front Endocrinol (Lausanne) 2020;11:556610. [PMID: 33162933 DOI: 10.3389/fendo.2020.556610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
203 González-Sanmiguel J, Burgos CF, Bascuñán D, Fernández-Pérez EJ, Riffo-Lepe N, Boopathi S, Fernández-Pérez A, Bobadilla-Azócar C, González W, Figueroa M, Vicente B, Aguayo LG. Gabapentin Inhibits Multiple Steps in the Amyloid Beta Toxicity Cascade. ACS Chem Neurosci 2020;11:3064-76. [PMID: 32886489 DOI: 10.1021/acschemneuro.0c00414] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
204 Cava C, Castiglioni I. Integration of Molecular Docking and In Vitro Studies: A Powerful Approach for Drug Discovery in Breast Cancer. Applied Sciences 2020;10:6981. [DOI: 10.3390/app10196981] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
205 Fahimian G, Zahiri J, Arab SS, Sajedi RH. RepCOOL: computational drug repositioning via integrating heterogeneous biological networks. J Transl Med 2020;18:375. [PMID: 33008415 DOI: 10.1186/s12967-020-02541-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
206 Nath J, Paul R, Ghosh SK, Paul J, Singha B, Debnath N. Drug repurposing and relabeling for cancer therapy: Emerging benzimidazole antihelminthics with potent anticancer effects. Life Sciences 2020;258:118189. [DOI: 10.1016/j.lfs.2020.118189] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 13.0] [Reference Citation Analysis]
207 Jubie S, Durai U, Latha S, Ayyamperumal S, Wadhwani A, Prabha T. Repurposing of Benzimidazole Scaffolds for HER2 Positive Breast Cancer Therapy: An In-Silico Approach. Curr Drug Res Rev 2021;13:73-83. [PMID: 32955008 DOI: 10.2174/2589977512999200821170221] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
208 Low ZY, Farouk IA, Lal SK. Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak. Viruses 2020;12:E1058. [PMID: 32972027 DOI: 10.3390/v12091058] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 18.5] [Reference Citation Analysis]
209 El-Husseini ZW, Gosens R, Dekker F, Koppelman GH. The genetics of asthma and the promise of genomics-guided drug target discovery. Lancet Respir Med 2020;8:1045-56. [PMID: 32910899 DOI: 10.1016/S2213-2600(20)30363-5] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 20.5] [Reference Citation Analysis]
210 Villas-Boas GR, Rescia VC, Paes MM, Lavorato SN, Magalhães-Filho MF, Cunha MS, Simões RDC, Lacerda RB, Freitas-Júnior RS, Ramos BHDS, Mapeli AM, Henriques MDST, Freitas WR, Lopes LAF, Oliveira LGR, Silva JGD, Silva-Filho SE, Silveira APSD, Leão KV, Matos MMS, Fernandes JS, Cuman RKN, Silva-Comar FMS, Comar JF, Brasileiro LDA, Santos JND, Oesterreich SA. The New Coronavirus (SARS-CoV-2): A Comprehensive Review on Immunity and the Application of Bioinformatics and Molecular Modeling to the Discovery of Potential Anti-SARS-CoV-2 Agents. Molecules 2020;25:E4086. [PMID: 32906733 DOI: 10.3390/molecules25184086] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
211 Ji X, Jin C, Dong X, Dixon MS, Williams KP, Zheng W. Literature-Wide Association Studies (LWAS) for a Rare Disease: Drug Repurposing for Inflammatory Breast Cancer. Molecules 2020;25:E3933. [PMID: 32872166 DOI: 10.3390/molecules25173933] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
212 Dai W, Li L, Guo D. Integrating bioassay data for improved prediction of drug-target interaction. Biophys Chem 2020;266:106455. [PMID: 32835911 DOI: 10.1016/j.bpc.2020.106455] [Reference Citation Analysis]
213 Wall G, Lopez-Ribot JL. Screening Repurposing Libraries for Identification of Drugs with Novel Antifungal Activity. Antimicrob Agents Chemother 2020;64:e00924-20. [PMID: 32660991 DOI: 10.1128/AAC.00924-20] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
214 Pérez-Plasencia C, López-Urrutia E, García-Castillo V, Trujano-Camacho S, López-Camarillo C, Campos-Parra AD. Interplay Between Autophagy and Wnt/β-Catenin Signaling in Cancer: Therapeutic Potential Through Drug Repositioning. Front Oncol 2020;10:1037. [PMID: 33014767 DOI: 10.3389/fonc.2020.01037] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
215 Parvathaneni V, Gupta V. Utilizing drug repurposing against COVID-19 - Efficacy, limitations, and challenges. Life Sci. 2020;259:118275. [PMID: 32818545 DOI: 10.1016/j.lfs.2020.118275] [Cited by in Crossref: 58] [Cited by in F6Publishing: 66] [Article Influence: 29.0] [Reference Citation Analysis]
216 Beklen H, Gulfidan G, Arga KY, Mardinoglu A, Turanli B. Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer. Front Oncol. 2020;10:1273. [PMID: 32903699 DOI: 10.3389/fonc.2020.01273] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
217 Hayden MR. Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019. J Int Med Res. 2020;48:300060520939746. [PMID: 32722979 DOI: 10.1177/0300060520939746] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
218 Sharma P, Vijayan V, Pant P, Sharma M, Vikram N, Kaur P, Singh TP, Sharma S. Identification of potential drug candidates to combat COVID-19: a structural study using the main protease (mpro) of SARS-CoV-2. J Biomol Struct Dyn 2021;39:6649-59. [PMID: 32741313 DOI: 10.1080/07391102.2020.1798286] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
219 Napoli PE, Mangoni L, Gentile P, Braghiroli M, Fossarello M. A Panel of Broad-Spectrum Antivirals in Topical Ophthalmic Medications from the Drug Repurposing Approach during and after the Coronavirus Disease 2019 Era. J Clin Med 2020;9:E2441. [PMID: 32751615 DOI: 10.3390/jcm9082441] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 14.5] [Reference Citation Analysis]
220 Fontinha D, Moules I, Prudêncio M. Repurposing Drugs to Fight Hepatic Malaria Parasites. Molecules 2020;25:E3409. [PMID: 32731386 DOI: 10.3390/molecules25153409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
221 Florent R, Poulain L, N'Diaye M. Drug Repositioning of the α1-Adrenergic Receptor Antagonist Naftopidil: A Potential New Anti-Cancer Drug? Int J Mol Sci 2020;21:E5339. [PMID: 32727149 DOI: 10.3390/ijms21155339] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
222 Fang J, Pieper AA, Nussinov R, Lee G, Bekris L, Leverenz JB, Cummings J, Cheng F. Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing. Med Res Rev 2020;40:2386-426. [PMID: 32656864 DOI: 10.1002/med.21709] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
223 Alves TFR, Rios AC, da Silva Pontes K, Portella DL, Aranha N, Severino P, Souto EB, Gonsalves JKM, de Souza Nunes R, Chaud MV. Bilayer Mucoadhesive Buccal Film for Mucosal Ulcers Treatment: Development, Characterization, and Single Study Case. Pharmaceutics 2020;12:E657. [PMID: 32664574 DOI: 10.3390/pharmaceutics12070657] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
224 Mohanty S, Harun Ai Rashid M, Mridul M, Mohanty C, Swayamsiddha S. Application of Artificial Intelligence in COVID-19 drug repurposing. Diabetes Metab Syndr 2020;14:1027-31. [PMID: 32634717 DOI: 10.1016/j.dsx.2020.06.068] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 41.0] [Reference Citation Analysis]
225 Gelosa P, Castiglioni L, Camera M, Sironi L. Drug repurposing in cardiovascular diseases: Opportunity or hopeless dream? Biochemical Pharmacology 2020;177:113894. [DOI: 10.1016/j.bcp.2020.113894] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
226 Shukla R, Henkel ND, Alganem K, Hamoud AR, Reigle J, Alnafisah RS, Eby HM, Imami AS, Creeden JF, Miruzzi SA, Meller J, Mccullumsmith RE. Signature-based approaches for informed drug repurposing: targeting CNS disorders. Neuropsychopharmacology 2021;46:116-30. [PMID: 32604402 DOI: 10.1038/s41386-020-0752-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
227 Wu D, Gao W, Li X, Tian C, Jiao N, Fang S, Xiao J, Xu Z, Zhu L, Zhang G, Zhu R. Dr AFC: drug repositioning through anti-fibrosis characteristic. Brief Bioinform 2021;22:bbaa115. [PMID: 32572450 DOI: 10.1093/bib/bbaa115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
228 Gadebusch Bondio M, Marloth M. [The "Historic Study" SOLIDARITY-Research's Answer to the Sars-CoV-2 Pandemic]. NTM 2020;28:219-25. [PMID: 32399903 DOI: 10.1007/s00048-020-00257-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
229 Lau A, So HC. Turning genome-wide association study findings into opportunities for drug repositioning. Comput Struct Biotechnol J 2020;18:1639-50. [PMID: 32670504 DOI: 10.1016/j.csbj.2020.06.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
230 Li B, Dai C, Wang L, Deng H, Li Y, Guan Z, Ni H. A novel drug repurposing approach for non-small cell lung cancer using deep learning. PLoS One 2020;15:e0233112. [PMID: 32525938 DOI: 10.1371/journal.pone.0233112] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
231 Kohno M, Musashi K, Ikeda HO, Horibe T, Matsumoto A, Kawakami K. Oral administration of ferulic acid or ethyl ferulate attenuates retinal damage in sodium iodate-induced retinal degeneration mice. Sci Rep 2020;10:8688. [PMID: 32457394 DOI: 10.1038/s41598-020-65673-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
232 Rameshrad M, Ghafoori M, Mohammadpour AH, Nayeri MJD, Hosseinzadeh H. A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19). Naunyn Schmiedebergs Arch Pharmacol 2020;393:1137-52. [PMID: 32430617 DOI: 10.1007/s00210-020-01901-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 13.5] [Reference Citation Analysis]
233 Lai J, Hu J, Wang Y, Zhou X, Li Y, Zhang L, Liu Z. Privileged Scaffold Analysis of Natural Products with Deep Learning-based Indication Prediction Model. Mol Inform 2020;39:e2000057. [PMID: 32406179 DOI: 10.1002/minf.202000057] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
234 Zaza P, Matthieu R, Jean-Luc C, Charles K. Drug repurposing in Raynaud's phenomenon through adverse event signature matching in the World Health Organization pharmacovigilance database. Br J Clin Pharmacol 2020;86:2217-22. [PMID: 32337731 DOI: 10.1111/bcp.14322] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
235 Kaushik I, Ramachandran S, Prasad S, Srivastava SK. Drug rechanneling: A novel paradigm for cancer treatment. Semin Cancer Biol 2021;68:279-90. [PMID: 32437876 DOI: 10.1016/j.semcancer.2020.03.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
236 Gysi DM, Nowick K. Construction, comparison and evolution of networks in life sciences and other disciplines. J R Soc Interface 2020;17:20190610. [PMID: 32370689 DOI: 10.1098/rsif.2019.0610] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
237 Kubick N, Pajares M, Enache I, Manda G, Mickael ME. Repurposing Zileuton as a Depression Drug Using an AI and In Vitro Approach. Molecules 2020;25:E2155. [PMID: 32380663 DOI: 10.3390/molecules25092155] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
238 Kirtonia A, Gala K, Fernandes SG, Pandya G, Pandey AK, Sethi G, Khattar E, Garg M. Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics. Semin Cancer Biol 2021;68:258-78. [PMID: 32380233 DOI: 10.1016/j.semcancer.2020.04.006] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 26.0] [Reference Citation Analysis]
239 Zhao T, Hu Y, Valsdottir LR, Zang T, Peng J. Identifying drug-target interactions based on graph convolutional network and deep neural network. Brief Bioinform 2021;22:2141-50. [PMID: 32367110 DOI: 10.1093/bib/bbaa044] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 46.0] [Reference Citation Analysis]
240 Sohraby F, Aryapour H. Rational drug repurposing for cancer by inclusion of the unbiased molecular dynamics simulation in the structure-based virtual screening approach: Challenges and breakthroughs. Semin Cancer Biol 2021;68:249-57. [PMID: 32360530 DOI: 10.1016/j.semcancer.2020.04.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
241 Shukla R, Henkel ND, Alganem K, Hamoud A, Reigle J, Alnafisah RS, Eby HM, Imami AS, Creeden J, Miruzzi SA, Meller J, Mccullumsmith RE. Integrative Omics for Informed Drug Repurposing: Targeting CNS Disorders.. [DOI: 10.1101/2020.04.24.060392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
242 Kaushik AC, Mehmood A, Dai X, Wei DQ. A comparative chemogenic analysis for predicting Drug-Target Pair via Machine Learning Approaches. Sci Rep 2020;10:6870. [PMID: 32322011 DOI: 10.1038/s41598-020-63842-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
243 Muralidharan N, Sakthivel R, Velmurugan D, Gromiha MM. Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19. Journal of Biomolecular Structure and Dynamics 2021;39:2673-8. [DOI: 10.1080/07391102.2020.1752802] [Cited by in Crossref: 235] [Cited by in F6Publishing: 221] [Article Influence: 117.5] [Reference Citation Analysis]
244 Berdigaliyev N, Aljofan M. An overview of drug discovery and development. Future Med Chem 2020;12:939-47. [PMID: 32270704 DOI: 10.4155/fmc-2019-0307] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 21.5] [Reference Citation Analysis]
245 Anasir MI, Ramanathan B, Poh CL. Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus. Viruses 2020;12:E367. [PMID: 32225021 DOI: 10.3390/v12040367] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
246 Parvathaneni V, Kulkarni NS, Shukla SK, Farrales PT, Kunda NK, Muth A, Gupta V. Systematic Development and Optimization of Inhalable Pirfenidone Liposomes for Non-Small Cell Lung Cancer Treatment. Pharmaceutics 2020;12:E206. [PMID: 32121070 DOI: 10.3390/pharmaceutics12030206] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 19.0] [Reference Citation Analysis]
247 Pereira CA, Sayé M, Reigada C, Silber AM, Labadie GR, Miranda MR, Valera-vera E. Computational approaches for drug discovery against trypanosomatid-caused diseases. Parasitology 2020;147:611-33. [DOI: 10.1017/s0031182020000207] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
248 Hwang H, Kim TY, Szász MA, Dome B, Malm J, Marko‐varga G, Kwon HJ. Profiling the Protein Targets of Unmodified Bio‐Active Molecules with Drug Affinity Responsive Target Stability and Liquid Chromatography/Tandem Mass Spectrometry. Proteomics 2020;20:1900325. [DOI: 10.1002/pmic.201900325] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
249 Nabirotchkin S, Peluffo AE, Rinaudo P, Yu J, Hajj R, Cohen D. Next-generation drug repurposing using human genetics and network biology. Curr Opin Pharmacol 2020;51:78-92. [PMID: 31982325 DOI: 10.1016/j.coph.2019.12.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 21.5] [Reference Citation Analysis]
250 Petković B, Kesić S, Pešić V. Critical View on the Usage of Ribavirin in Already Existing Psychostimulant-Use Disorder. Curr Pharm Des 2020;26:466-84. [PMID: 31939725 DOI: 10.2174/1381612826666200115094642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
251 Ölgen S. Clinical trials on combination of repurposed drugs and anticancer therapies. Drug Repurposing in Cancer Therapy 2020. [DOI: 10.1016/b978-0-12-819668-7.00015-4] [Reference Citation Analysis]
252 Gns H, Prasannamarise VL, Pai RR, Mariam Jos S, Krishna Murthy M, Saraswathy GR. Unveiling potential anticancer drugs through in silico drug repurposing approaches. Drug Repurposing in Cancer Therapy 2020. [DOI: 10.1016/b978-0-12-819668-7.00004-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
253 Chang HK, Chang VH. Animal models and in vivo investigations for drug repurposing in lung cancer. Drug Repurposing in Cancer Therapy 2020. [DOI: 10.1016/b978-0-12-819668-7.00010-5] [Reference Citation Analysis]
254 Pathak RK, Singh DB, Sagar M, Baunthiyal M, Kumar A. Computational Approaches in Drug Discovery and Design. Computer-Aided Drug Design 2020. [DOI: 10.1007/978-981-15-6815-2_1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
255 Sosa DN, Derry A, Guo M, Wei E, Brinton C, Altman RB. A Literature-Based Knowledge Graph Embedding Method for Identifying Drug Repurposing Opportunities in Rare Diseases. Pac Symp Biocomput 2020;25:463-74. [PMID: 31797619] [Reference Citation Analysis]
256 Chakraborti S, Chakravarthi P, Srinivasan N. A ligand-centric approach to identify potential drugs for repurposing. Drug Repurposing in Cancer Therapy 2020. [DOI: 10.1016/b978-0-12-819668-7.00002-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
257 Réda C, Kaufmann E, Delahaye-Duriez A. Machine learning applications in drug development. Comput Struct Biotechnol J 2020;18:241-52. [PMID: 33489002 DOI: 10.1016/j.csbj.2019.12.006] [Cited by in Crossref: 81] [Cited by in F6Publishing: 84] [Article Influence: 27.0] [Reference Citation Analysis]
258 Gajdács M, Spengler G. The Role of Drug Repurposing in the Development of Novel Antimicrobial Drugs: Non-Antibiotic Pharmacological Agents as Quorum Sensing-Inhibitors. Antibiotics (Basel) 2019;8:E270. [PMID: 31861228 DOI: 10.3390/antibiotics8040270] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
259 Joshi SV, Patel EP, Vyas BA, Lodha SR, Kalyankar GG. Repurposing of Iloperidone: Antihypertensive and ocular hypotensive activity in animals. Eur J Pharm Sci 2020;143:105173. [PMID: 31809906 DOI: 10.1016/j.ejps.2019.105173] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
260 Singh AV, Negi A. Towards Better Drug Repositioning Using Joint Learning. 2019 IEEE 16th India Council International Conference (INDICON) 2019. [DOI: 10.1109/indicon47234.2019.9029004] [Reference Citation Analysis]
261 de S. Machado C, da Rosa TF, Serafin MB, Bottega A, Coelho SS, Foletto VS, Rampelotto RF, Lorenzoni VV, de L. Marion S, Hörner R. In vitro evaluation of the antibacterial activity of amitriptyline and its synergistic effect with ciprofloxacin, sulfamethoxazole–trimethoprim, and colistin as an alternative in drug repositioning. Med Chem Res 2020;29:166-77. [DOI: 10.1007/s00044-019-02470-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
262 Moridi M, Ghadirinia M, Sharifi-Zarchi A, Zare-Mirakabad F. The assessment of efficient representation of drug features using deep learning for drug repositioning. BMC Bioinformatics 2019;20:577. [PMID: 31726977 DOI: 10.1186/s12859-019-3165-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
263 Wang L, Ding J, Pan L, Cao D, Jiang H, Ding X. Artificial intelligence facilitates drug design in the big data era. Chemometrics and Intelligent Laboratory Systems 2019;194:103850. [DOI: 10.1016/j.chemolab.2019.103850] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
264 Natarajan A, Thangarajan R, Kesavan S. Repurposing Drugs by In Silico Methods to Target BCR Kinase Domain in Chronic Myeloid Leukemia. Asian Pac J Cancer Prev 2019;20:3399-406. [PMID: 31759365 DOI: 10.31557/APJCP.2019.20.11.3399] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
265 Koromina M, Pandi MT, Patrinos GP. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics. OMICS 2019;23:539-48. [PMID: 31651216 DOI: 10.1089/omi.2019.0151] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 12.3] [Reference Citation Analysis]
266 Andersen PI, Krpina K, Ianevski A, Shtaida N, Jo E, Yang J, Koit S, Tenson T, Hukkanen V, Anthonsen MW, Bjoras M, Evander M, Windisch MP, Zusinaite E, Kainov DE. Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine. Viruses 2019;11:E964. [PMID: 31635418 DOI: 10.3390/v11100964] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 17.3] [Reference Citation Analysis]
267 Yang G, Ma A, Qin ZS. An Integrated System Biology Approach Yields Drug Repositioning Candidates for the Treatment of Heart Failure. Front Genet 2019;10:916. [PMID: 31608126 DOI: 10.3389/fgene.2019.00916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
268 Sanomachi T, Suzuki S, Togashi K, Sugai A, Seino S, Okada M, Yoshioka T, Kitanaka C, Yamamoto M. Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs. Cancers (Basel) 2019;11:E1550. [PMID: 31614999 DOI: 10.3390/cancers11101550] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
269 Turanli B, Altay O, Borén J, Turkez H, Nielsen J, Uhlen M, Arga KY, Mardinoglu A. Systems biology based drug repositioning for development of cancer therapy. Semin Cancer Biol 2021;68:47-58. [PMID: 31568815 DOI: 10.1016/j.semcancer.2019.09.020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 10.7] [Reference Citation Analysis]
270 Mihai DP, Nitulescu GM, Ion GND, Ciotu CI, Chirita C, Negres S. Computational Drug Repurposing Algorithm Targeting TRPA1 Calcium Channel as a Potential Therapeutic Solution for Multiple Sclerosis. Pharmaceutics 2019;11:E446. [PMID: 31480671 DOI: 10.3390/pharmaceutics11090446] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
271 Bailly C. Toward a repositioning of the antibacterial drug nifuroxazide for cancer treatment. Drug Discovery Today 2019;24:1930-6. [DOI: 10.1016/j.drudis.2019.06.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
272 Kumar R, Harilal S, Gupta SV, Jose J, Thomas Parambi DG, Uddin MS, Shah MA, Mathew B. Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work. Eur J Med Chem 2019;182:111602. [PMID: 31421629 DOI: 10.1016/j.ejmech.2019.111602] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
273 Sosa DN, Derry A, Guo M, Wei E, Brinton C, Altman RB. A Literature-Based Knowledge Graph Embedding Method for Identifying Drug Repurposing Opportunities in Rare Diseases.. [DOI: 10.1101/727925] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
274 Conte F, Fiscon G, Licursi V, Bizzarri D, D'Antò T, Farina L, Paci P. A paradigm shift in medicine: A comprehensive review of network-based approaches. Biochim Biophys Acta Gene Regul Mech 2020;1863:194416. [PMID: 31382052 DOI: 10.1016/j.bbagrm.2019.194416] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 15.7] [Reference Citation Analysis]
275 Abdelaziz AI, Mantawy EM, Gad AM, Fawzy HM, Azab SS. Activation of pCREB/Nrf-2 signaling mediates re-positioning of liraglutide as hepato-protective for methotrexate -induced liver injury (MILI). Food Chem Toxicol 2019;132:110719. [PMID: 31362085 DOI: 10.1016/j.fct.2019.110719] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
276 Kim IW, Kim JH, Oh JM. Screening of Drug Repositioning Candidates for Castration Resistant Prostate Cancer. Front Oncol 2019;9:661. [PMID: 31396486 DOI: 10.3389/fonc.2019.00661] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
277 Paranjpe MD, Taubes A, Sirota M. Insights into Computational Drug Repurposing for Neurodegenerative Disease. Trends Pharmacol Sci 2019;40:565-76. [PMID: 31326236 DOI: 10.1016/j.tips.2019.06.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 13.3] [Reference Citation Analysis]
278 Abels C, Soeberdt M. Can we teach old drugs new tricks?—Repurposing of neuropharmacological drugs for inflammatory skin diseases. Exp Dermatol 2019;28:1002-9. [DOI: 10.1111/exd.13987] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
279 Veselkov K, Gonzalez G, Aljifri S, Galea D, Mirnezami R, Youssef J, Bronstein M, Laponogov I. HyperFoods: Machine intelligent mapping of cancer-beating molecules in foods. Sci Rep. 2019;9:9237. [PMID: 31270435 DOI: 10.1038/s41598-019-45349-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
280 Kim S. Pathway Interactions Based on Drug-Induced Datasets. Cancer Inform 2019;18:1176935119851518. [PMID: 31205412 DOI: 10.1177/1176935119851518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
281 Clout AE, Della Pasqua O, Hanna MG, Orlu M, Pitceathly RDS. Drug repurposing in neurological diseases: an integrated approach to reduce trial and error. J Neurol Neurosurg Psychiatry 2019;90:1270-5. [PMID: 31171583 DOI: 10.1136/jnnp-2019-320879] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
282 Qian T, Zhu S, Hoshida Y. Use of big data in drug development for precision medicine: an update. Expert Rev Precis Med Drug Dev. 2019;4:189-200. [PMID: 31286058 DOI: 10.1080/23808993.2019.1617632] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 10.7] [Reference Citation Analysis]
283 Mickael M, Pajares M, Enache I, Manda G, Cuadrado A. NRF2 drug repurposing using a question-answer artificial intelligence system.. [DOI: 10.1101/594622] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
284 Piccirillo G, Carvajal Berrio DA, Laurita A, Pepe A, Bochicchio B, Schenke-Layland K, Hinderer S. Controlled and tuneable drug release from electrospun fibers and a non-invasive approach for cytotoxicity testing. Sci Rep 2019;9:3446. [PMID: 30837604 DOI: 10.1038/s41598-019-40079-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
285 Arrouchi H, Lakhlili W, Ibrahimi A. Re-positioning of known drugs for Pim-1 kinase target using molecular docking analysis. Bioinformation 2019;15:116-20. [PMID: 31435157 DOI: 10.6026/97320630015116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
286 Prakash O, Nath Dwivedi U. Identification of repurposed protein kinase B binders from FDA-approved drug library: a hybrid-structure activity relationship and systems modeling based approach. J Biomol Struct Dyn 2020;38:660-72. [PMID: 30806166 DOI: 10.1080/07391102.2019.1585293] [Reference Citation Analysis]
287 Kim IW, Jang H, Kim JH, Kim MG, Kim S, Oh JM. Computational Drug Repositioning for Gastric Cancer using Reversal Gene Expression Profiles. Sci Rep 2019;9:2660. [PMID: 30804389 DOI: 10.1038/s41598-019-39228-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
288 Luo Y, Zeng A, Fang A, Song L, Fan C, Zeng C, Ye T, Chen H, Tu C, Xie Y. Nifuroxazide induces apoptosis, inhibits cell migration and invasion in osteosarcoma. Invest New Drugs 2019;37:1006-13. [PMID: 30680584 DOI: 10.1007/s10637-019-00724-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
289 Brueggeman L, Sturgeon ML, Martin RM, Grossbach AJ, Nagahama Y, Zhang A, Howard MA 3rd, Kawasaki H, Wu S, Cornell RA, Michaelson JJ, Bassuk AG. Drug repositioning in epilepsy reveals novel antiseizure candidates. Ann Clin Transl Neurol 2019;6:295-309. [PMID: 30847362 DOI: 10.1002/acn3.703] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
290 Rameshrad M, Razavi BM, Lalau JD, De Broe ME, Hosseinzadeh H. An overview of glucagon-like peptide-1 receptor agonists for the treatment of metabolic syndrome: A drug repositioning. Iran J Basic Med Sci 2020;23:556-68. [PMID: 32742592 DOI: 10.22038/ijbms.2020.41638.9832] [Cited by in F6Publishing: 2] [Reference Citation Analysis]